Key facts
- Manuals
- 1
- Languages
- ZH
- Last added
- 2026-09-30
Featured 达伯舒 manuals
Daboshu Injection Product Leaflet
Daboshu (Sintilimab) Injection is a recombinant fully‑human anti‑PD‑1 monoclonal antibody supplied as a clear to slightly milky, colorless to pale‑yellow liquid. Each vial contains 100 mg of active ingredient in 10 ml of solution and is intended for intravenous infusion under physician supervision.
The label provides detailed instructions on dosage (200 mg IV every 3 weeks), preparation (do not shake, bring to room temperature, dilute with 0.9 % NaCl), contraindications (allergy to the active ingredient or excipients), and comprehensive safety information including adverse‑reaction management and special‑population considerations. This manual is written in Chinese.
Covers: 药品名称 · 成份 · 性状 · 适应症 · 规格 · 用法用量
Latest 达伯舒 manuals
Daboshu Injection Product Leaflet
Product Leaflet 2 pages · 830 KB · ZHDaboshu Injection is a 100 mg/10 ml vial of Sintilimab for intravenous infusion, with dosage, preparation, and safety information.
Questions answered in 达伯舒 manuals
What is the recommended dosage of Daboshu Injection?
The recommended dosage is 200 mg administered by intravenous infusion once every 3 weeks until disease progression or unacceptable toxicity.
What are the contraindications for Daboshu Injection?
Patients who are allergic to the active ingredient or any of the excipients must not use the product.